GLP-1 receptor agonists are prescription medications, and decisions about your treatment, dose, and management of side effects should be made with your prescribing clinician
The data was acquired and analyzed using MassHunter software (version 5.0.280.1
Key Leaders: Nathan Hubbard, CEO Number of Employees: More than 2,500 Stage: Acquired Financial Snapshot: Valued at $1.9 billion during acquisition Notable Investors: Roche, Google Ventures (GV), Allen & Company, Baillie Gifford, and Casdin Capital Key Product: Flatiron Health offers OncoEMR, an electronic medical record (EMR) system that helps medical teams manage patient data and treatment plans and streamline internal workflows
Active individuals focused on physical performance*
The combination of redox buffering and inflammatory damping is a recurring theme across the compound's reported applications